Aspa Therapeutics careers

BridgeBio founded Aspa with the sole purpose of developing a gene therapy to treat patients with Canavan disease. They have assembled a leadership team with extensive experience in developing therapies for rare diseases.

Aspa is dedicated to collaborating with Canavan patient advocacy groups and families affected by Canavan disease throughout the development process.